These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 11112449)
21. TNF-alpha increases expression of IL-6 and ICAM-1 genes through activation of NF-kappaB in osteoblast-like ROS17/2.8 cells. Kurokouchi K; Kambe F; Yasukawa K; Izumi R; Ishiguro N; Iwata H; Seo H J Bone Miner Res; 1998 Aug; 13(8):1290-9. PubMed ID: 9718198 [TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B. Goto M; Yamada K; Katayama K; Tanaka I Mol Pharmacol; 1996 May; 49(5):860-73. PubMed ID: 8622636 [TBL] [Abstract][Full Text] [Related]
23. Bcl-2 suppresses apoptosis resulting from disruption of the NF-kappa B survival pathway. Herrmann JL; Beham AW; Sarkiss M; Chiao PJ; Rands MT; Bruckheimer EM; Brisbay S; McDonnell TJ Exp Cell Res; 1997 Nov; 237(1):101-9. PubMed ID: 9417872 [TBL] [Abstract][Full Text] [Related]
24. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of ceramide pathway does not affect ability of TNF-alpha to activate nuclear factor-kappa B. Johns LD; Sarr T; Ranges GE J Immunol; 1994 Jun; 152(12):5877-82. PubMed ID: 8207213 [TBL] [Abstract][Full Text] [Related]
27. Nuclear factor-kappa B mediates TNF-alpha inhibitory effect on alpha 2(I) collagen (COL1A2) gene transcription in human dermal fibroblasts. Kouba DJ; Chung KY; Nishiyama T; Vindevoghel L; Kon A; Klement JF; Uitto J; Mauviel A J Immunol; 1999 Apr; 162(7):4226-34. PubMed ID: 10201951 [TBL] [Abstract][Full Text] [Related]
28. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase. Manna SK; Sah NK; Newman RA; Cisneros A; Aggarwal BB Cancer Res; 2000 Jul; 60(14):3838-47. PubMed ID: 10919658 [TBL] [Abstract][Full Text] [Related]
29. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha. Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518 [TBL] [Abstract][Full Text] [Related]
31. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells. McDade TP; Perugini RA; Vittimberga FJ; Carrigan RC; Callery MP J Surg Res; 1999 May; 83(1):56-61. PubMed ID: 10210643 [TBL] [Abstract][Full Text] [Related]
32. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells. Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391 [TBL] [Abstract][Full Text] [Related]
33. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene. Nanes MS; Kuno H; Demay MB; Kurian M; Hendy GN; DeLuca HF; Titus L; Rubin J Endocrinology; 1994 Mar; 134(3):1113-20. PubMed ID: 8119149 [TBL] [Abstract][Full Text] [Related]
34. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080 [TBL] [Abstract][Full Text] [Related]
35. An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts. Anisowicz A; Messineo M; Lee SW; Sager R J Immunol; 1991 Jul; 147(2):520-7. PubMed ID: 1906501 [TBL] [Abstract][Full Text] [Related]
36. Monitoring NF-kappa B transactivation potential via real-time PCR quantification of I kappa B-alpha gene expression. Bottero V; Imbert V; Frelin C; Formento JL; Peyron JF Mol Diagn; 2003; 7(3-4):187-94. PubMed ID: 15068390 [TBL] [Abstract][Full Text] [Related]
37. Reconstitution of nuclear factor kappa B activation induced by tumor necrosis factor requires membrane-associated components. Comparison with pathway activated by ceramide. Reddy SA; Chaturvedi MM; Darnay BG; Chan H; Higuchi M; Aggarwal BB J Biol Chem; 1994 Oct; 269(41):25369-72. PubMed ID: 7929233 [TBL] [Abstract][Full Text] [Related]
38. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. Peng HB; Libby P; Liao JK J Biol Chem; 1995 Jun; 270(23):14214-9. PubMed ID: 7775482 [TBL] [Abstract][Full Text] [Related]
40. Activation of NF-kappaB in human osteoblasts by stimulators of bone resorption. Ali NN; Gilston V; Winyard PG FEBS Lett; 1999 Oct; 460(2):315-20. PubMed ID: 10544256 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]